A Randomized Double-Blind Study with an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide with Placebo in Pediatric Patients with Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)
Investigating Weekly Treatment for Type 2 Diabetes in Children
Brief description of study.
The purpose of this study is to evaluate the use of once weekly dulaglutide compared with placebo in pediatric patients with type 2 diabetes mellitus who have inadequate glycemic control despite diet and exercise, with or without metformin and/or basal insulin.
Detailed description of study
The purpose of this study is to evaluate the use of once weekly dulaglutide compared with placebo in pediatric patients with type 2 diabetes mellitus who have inadequate glycemic control despite diet and exercise, with or without metformin and/or basal insulin.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: type 2 diabetes
-
Age: 100 years or below
-
Gender: All
This study investigates the use of a weekly investigational medication compared to a placebo in children with type 2 diabetes. Type 2 diabetes is a condition where the body has trouble using sugar for energy, leading to high blood sugar levels. This study is for children who cannot control their blood sugar well with diet and exercise, even if they are taking metformin or insulin.
Participants will receive either the investigational medication or a placebo once a week. A placebo is an inactive substance that looks like the investigational medication but does not contain any medicine. The study will compare the effects of the investigational medication and the placebo on blood sugar levels.
- Who can participate: Children with type 2 diabetes who cannot control their blood sugar with diet and exercise are eligible.
- Study details: Participants will receive a weekly dose of either the investigational medication or a placebo. A placebo is an inactive substance that looks like the investigational medication but does not contain any medicine.
